1,001
Views
7
CrossRef citations to date
0
Altmetric
Research Report

The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use

, , , , , , , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Konstantin Tachkov, Vladimira Boyadzhieva, Ivan Manev, Nikolay Stoilov, Zornitsa Mitkova, Konstantin Mitov & Guenka Petrova. (2022) Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level. Biotechnology & Biotechnological Equipment 36:1, pages 828-837.
Read now
Emanuela Zagni, Delia Colombo, Martina Fiocchi, Valentina Perrone, Diego Sangiorgi, Margherita Andretta, Giovambattista De Sarro, Eduardo Nava & Luca Degli Esposti. (2020) Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting. Expert Review of Pharmacoeconomics & Outcomes Research 20:5, pages 491-497.
Read now

Articles from other publishers (5)

Jami Sayed Abdulla, Jiandang Shi, Brotendu Shekhar Roy, Zhou Zhanwen & Changhao Liu. (2020) RETRACTED ARTICLE: Patients with ankylosing spondylitis treatment by golimumab: a systematic review and meta-analysis. European Spine Journal 29:8, pages 1813-1822.
Crossref
Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling, Adrian Ciurea, Herman Mann, Fatos Onen, Eirik Klami Kristianslund, Dan Nordström, Maria Jose Santos, Catalin Codreanu, Juan Gómez-Reino, Ziga Rotar, Bjorn Gudbjornsson, Daniela Di Giuseppe, Michael J Nissen, Karel Pavelka, Merih Birlik, Tore Kvien, Kari Kalervo Eklund, Anabela Barcelos, Ruxandra Ionescu, Carlos Sanchez-Piedra, Matija Tomsic, Árni Jón Geirsson, Anne Gitte Loft, Irene van der Horst-Bruinsma, Gareth Jones, Florenzo Iannone, Lise Hyldstrup, Niels Steen Krogh, Merete Lund Hetland & Mikkel Østergaard. (2019) Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Annals of the Rheumatic Diseases 78:11, pages 1536-1544.
Crossref
Mesfin Yimam, Teresa Horm, Laura Wright, Ping Jiao, Mei Hong, Lidia Brownell & Qi Jia. (2019) UP1306: A Composition Containing Standardized Extracts of Acacia catechu and Morus alba for Arthritis Management. Nutrients 11:2, pages 272.
Crossref
Jessica A Walsh, Oluwakayode Adejoro, Benjamin Chastek & Yujin Park. (2018) Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database. Journal of Comparative Effectiveness Research 7:4, pages 369-380.
Crossref
Sergio Schwartzman, Yunfeng Li, Huanxue Zhou & Jacqueline B. Palmer. (2017) Economic impact of biologic utilization patterns in patients with psoriatic arthritis. Clinical Rheumatology 36:7, pages 1579-1588.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.